Laboratory Results and Clinical Characteristics of Probable Omicron Patients at Dr. Wahidin Sudirohusodo Hospital

Author:

Fadhlan Fadhlan,Bahrun Uleng,Esa Tenri

Abstract

Since the Omicron variant was first detected on November 24, 2021, in Southern Africa, it has now been detected in more than 110 countries and is estimated to continue to spread. Given the rapid spread and serious dangers of COVID-19, it is urgent to continuously improve and expand research on its clinical diagnosis and treatment. The analysis of this study identifies the laboratory results and clinical characteristics of probable Omicron. This study aimed to determine the laboratory results and clinical characteristics of probable Omicron patients at Dr. Wahidin Sudirohusodo Hospital. This descriptive study used a cross-sectional approach with medical record data of probable Omicron patients at Dr. Wahidin Sudirohusodo Hospital from January to July 2022 with a total of 241 research subjects. The results of the analysis showed that probable Omicron patients at Dr. Wahidin Sudirohusodo Hospital who were hospitalized consisted of 124 (51.5%) males and 117 (48.5%) females, 66 (22.8%) subjects with age range >60 years, 88 (30.4%) subjects with age range of 40-60 years, 45 (15.6%) subjects with age range 19-40 years and 42 (14.5%) subjects with age <18. Most subjects, which consisted of 79 (27.3%) patients reside in Makassar. The mean WBC count, NLR value, LMR value, and CT value found in this study were 10.8; 5.6; 0.5; and 33.94, respectively. The Omicron variant infects more males than females mainly at the age of 40-60 years, with a relatively low average CT value of 33.94 and a slight increase of NLR, MLR, and WBC count.

Publisher

PDS Patklin

Reference26 articles.

1. Meo SA, Meo AS, Al-Jassir FF, Klonoff DC. Omicron SARS-CoV-2 new variant: Global prevalence and biological and clinical characteristics. Eur. Rev. Med. Pharmacol. Sci, 2021; 25: 8012-8018.

2. Wang X, Li X, Shang Yu, Wang J, Zhang X, et al. Ratios of neutrophil-to-lymphocyte and platelet-to-lymphocyte predict all-cause mortality in inpatients with Coronavirus Disease 2019 (COVID-19): A retrospective cohort study in a single medical center. Epidemiol. Infect, 2020; 148: e211.

3. Aleem A, Akbar Samad AB, Vaqar S. Emerging variants of SARS-CoV-2 and novel therapeutics against Coronavirus (COVID-19). 2023 May 1. Meo SA, Meo AS, Al-Jassir FF, Klonoff DC. Omicron SARS-CoV-2 new variant: Global prevalence and biological and clinical characteristics. Eur. Rev. Med. Pharmacol. Sci, 2021; 25: 8012-8018.

4. Wang X, Li X, Shang Yu, Wang J, Zhang X, et al. Ratios of neutrophil-to-lymphocyte and platelet-to-lymphocyte predict all-cause mortality in inpatients with Coronavirus Disease 2019 (COVID-19): A retrospective cohort study in a single medical center. Epidemiol. Infect, 2020; 148: e211.

5. Aleem A, Akbar Samad AB, Vaqar S. Emerging variants of SARS-CoV-2 and novel therapeutics against Coronavirus (COVID-19). 2023 May 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2023; PMID: 34033342.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3